IL-6 antibody shows no COVID-19 benefit

被引：0
|
作者：
Cross, Ryan
机构：
来源：
CHEMICAL & ENGINEERING NEWS | 2020年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [31] IL-6 Receptor Inhibitors in COVID-19: Efficacy on the Test Bench
    Wagner, Annkatrin
    TRANSFUSIONSMEDIZIN, 2021, 11 (03) : 151 - 151
  • [32] IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
    Atal, Shubham
    Fatima, Zeenat
    PHARMACEUTICAL MEDICINE, 2020, 34 (04) : 223 - 231
  • [33] Relationship between IL-6 and COVID-19: to be considered during treatment
    Vatansever, Hafize Seda
    Becer, Eda
    FUTURE VIROLOGY, 2020, 15 (12) : 817 - 822
  • [34] Perspectives on Targeting IL-6 as a Potential Therapeutic Strategy for COVID-19
    Khaedir, Yordan
    Kartika, Rona
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2021, 41 (02): : 37 - 43
  • [35] IL-6 modulation for COVID-19: the right patients at the right time?
    Ascierto, Paolo Antonio
    Fu, Binqing
    Wei, Haiming
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (04)
  • [36] The potential of COVID-19 patients’ sera to cause antibody-dependent enhancement of infection and IL-6 production
    Jun Shimizu
    Tadahiro Sasaki
    Atsushi Yamanaka
    Yoko Ichihara
    Ritsuko Koketsu
    Yoshihiro Samune
    Pedro Cruz
    Kei Sato
    Naomi Tanga
    Yuka Yoshimura
    Ami Murakami
    Misuzu Yamada
    Kiyoe Itoi
    Emi E. Nakayama
    Kazuo Miyazaki
    Tatsuo Shioda
    Scientific Reports, 11
  • [37] The potential of COVID-19 patients' sera to cause antibody-dependent enhancement of infection and IL-6 production
    Shimizu, Jun
    Sasaki, Tadahiro
    Yamanaka, Atsushi
    Ichihara, Yoko
    Koketsu, Ritsuko
    Samune, Yoshihiro
    Cruz, Pedro
    Sato, Kei
    Tanga, Naomi
    Yoshimura, Yuka
    Murakami, Ami
    Yamada, Misuzu
    Itoi, Kiyoe
    Nakayama, Emi E.
    Miyazaki, Kazuo
    Shioda, Tatsuo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients
    Saavedra, Danay
    Ane-Kouri, Ana Laura
    Sanchez, Naivy
    Filgueira, Lazaro Manuel
    Betancourt, Julio
    Herrera, Carlos
    Manso, Leniel
    Chavez, Elibet
    Caballero, Armando
    Hidalgo, Carlos
    Lorenzo, Geydi
    Cepeda, Meylan
    Valenzuela, Carmen
    Ramos, Mayra
    Leon, Kalet
    Mazorra, Zaima
    Crombet, Tania
    IMMUNITY & AGEING, 2020, 17 (01)
  • [39] An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients
    Danay Saavedra
    Ana Laura Añé-Kourí
    Naivy Sánchez
    Lázaro Manuel Filgueira
    Julio Betancourt
    Carlos Herrera
    Leniel Manso
    Elibet Chávez
    Armando Caballero
    Carlos Hidalgo
    Geydi Lorenzo
    Meylan Cepeda
    Carmen Valenzuela
    Mayra Ramos
    Kalet León
    Zaima Mazorra
    Tania Crombet
    Immunity & Ageing, 17
  • [40] Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19
    Mahmood, Saad B. Z.
    Majid, Hafsa
    Arshad, Ainan
    Zaib-Un-Nisa, Noureen
    Niazali, Noureen
    Kazi, Kulsum
    Aslam, Aashir
    Ahmed, Sibtain
    Jamil, Bushra
    Jafri, Lena
    CLINICAL LABORATORY, 2023, 69 (06) : 1126 - 1133
12345